Immunosuppression in islet transplantation

Journal of Clinical Investigation

Volumn 118, Issue 5, 2008, Pages 1625-1628

  Van Belle, Tom ^a   Von Herrath, Matthias ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CD3 ANTIBODY; CYCLOSPORIN A; DACLIZUMAB; ETANERCEPT; GLUTAMATE DECARBOXYLASE 65; IMMUNOSUPPRESSIVE AGENT; INSULIN; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 7; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROINSULIN; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL REGENERATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; GRAFT REJECTION; HOMEOSTASIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; LYMPHOCYTOPENIA; NONHUMAN; NOTE; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; GRAFT REJECTION; HOMEOSTASIS; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; T-LYMPHOCYTES, REGULATORY;

EID: 43049112086     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI35639     Document Type: Note

References (28)

1. Bach, J.F., and Chatenoud, L. 2001. Tolerance to islet autoantigens in type 1 diabetes. Annu. Rev. Immunol. 19:131-161.
2. Gianani, R., and Eisenbarth, G.S. 2005. The stages of type 1A diabetes: 2005. Immunol. Rev. 204:232-249.
3. Krupica, T., Jr., Fry, T.J., and Mackall, C.L. 2006. Autoimmunity during lymphopenia: a two-hit model. Clin. Immunol. 120:121-128.
4. Shapiro, A.M., et al. 2000. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:230-238.
5. Shapiro, A.M., et al. 2006. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 355:1318-1330.
6. Monti, P., et al. 2008. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. J. Clin. Invest. 118:1806-1814.
7. Huurman, V.A.L., et al. 2008. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS ONE. In press.
8. King, C., Ilic, A., Koelsch, K., and Sarvetnick, N. 2004. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell. 117:265-277.
9. Calzascia, T., et al. 2008. CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity. Proc. Natl. Acad. Sci. U. S. A. 105:2999-3004.
10. Wicker, L.S., et al. 1994. Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes. J. Exp. Med. 180:1705-1713.
11. Wesley, A., Coovadia, H.M., and Henderson, L. 1978. Immunological recovery after measles. Clin. Exp. Immunol. 32:540-544.
12. Lau, Y.L., and Peiris, J.S. 2005. Pathogenesis of severe acute respiratory syndrome. Curr. Opin. Immunol. 17:404-410.
13. Holm, C., Nyvold, C.G., Paludan, S.R., Thomsen, A.R., and Hokland, M. 2006. Interleukin-21 mRNA expression during virus infections. Cytokine. 33:41-45.
14. Marttila, J., Hyoty, H., Nanto-Salonen, K., Simell, O., and Ilonen, J. 2004. Epitopes recognized by CBV4 responding T cells: effect of type 1 diabetes and associated HLA-DR-DQ haplotypes. Virology. 319:27-35.
15. Ballotti, S., and de Martino, M. 2007. Rotavirus infections and development of type 1 diabetes: an evasive conundrum. J. Pediatr. Gastroenterol. Nutr. 45:147-156.
16. Surh, C.D., Boyman, O., Purton, J.F., and Sprent, J. 2006. Homeostasis of memory T cells. Immunol. Rev. 211:154-163.
17. Dooms, H., and Abbas, A.K. 2006. Control of CD4+ T-cell memory by cytokines and costimulators. Immunol. Rev. 211:23-38.
18. Purton, J.F., et al. 2007. Antiviral CD4+ memory T cells are IL-15 dependent. J. Exp. Med. 204:951-961.
19. de Kleer, I., et al. 2006. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood. 107:1696-1702.
20. Malek, T.R., and Bayer, A.L. 2004. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 4:665-674.
21. Boyman, O., Kovar, M., Rubinstein, M.P., Surh, C.D., and Sprent, J. 2006. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science. 311:1924-1927.
22. NIDDK. New onset of type 1 diabetes mycophenolate mofetil-daclizumab clinical trial [ClinicalTrials. gov study NCT00100178]. http://www. clinicaltrials. gov/ct2/show/NCT00100178.
23. Keymeulen, B., et al. 2005. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N. Engl. J. Med. 352:2598-2608.
24. Bresson, D., et al. 2006. Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J. Clin. Invest. 116:1371-1381.
25. NIAID. Islet transplantation in type 1 diabetes [ClinicalTrials.gov study NCT00434811]. http:// www.clinicaltrials.gov/ct2/show/NCT00434811.
26. Nir, T., Melton, D.A., and Dor, Y. 2007. Recovery from diabetes in mice by beta cell regeneration. J. Clin. Invest. 117:2553-2561.
27. Bayhill Therapeutics. Phase 1 study of BHT-3021 in subjects with type 1 diabetes mellitus [Clinical-Trials.gov study NCT00453375]. http://www. clinicaltrials. gov/ct2/show/NCT00453375.
28. NIDDK. Effects of recombinant human glutamic acid decarboxylase [ClinicalTrials.gov study NCT00529399]. http://www.clinicaltrials.gov/ct2/ show/NCT00529399.